Carbiogene Therapeutics Co. Ltd.
2 clinical trials · Sponsor
◉ Watch Carbiogene Therapeutics Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| Phase I Clinical Study of CBG002 CAR-T Cell in Treatment of Relapsed/refractory Multiple Myeloma (NCT06705725) | Carbiogene Therapeutics Co. Ltd. | 2024-12-26 |
| Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5) (NCT04803929) | Carbiogene Therapeutics Co. Ltd. | 2021-03-03 |
Track Carbiogene Therapeutics Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.